And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Edward P. Feener net worth and biography

Edward Feener Biography and Net Worth

Insider of KalVista Pharmaceuticals

Ed is a co-founder of KalVista and joined as Chief Scientific Officer in 2016. Previously, Dr. Feener was an Associate Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Vascular Cell Biology at Joslin Diabetes Center. He has 30 years of research experience in vascular biology and diabetic complications. His laboratory has performed pioneering research on the kallikrein kinin system and was first to identify plasma kallikrein as a potential therapeutic target for diabetic macular edema. Ed has published over 80 scientific articles and has served on multiple national and international scientific research review committees.

Ed received his PhD in Biochemistry from Boston University and completed postdoctoral training at the Joslin Diabetes Center and Harvard Medical School.

What is Edward P. Feener's net worth?: The estimated net worth of Edward P. Feener is at least $643,324.95 as of February 20th, 2024. Dr. Feener owns 62,157 shares of KalVista Pharmaceuticals stock worth more than $643,325 as of April 25th. This net worth evaluation does not reflect any other assets that Dr. Feener may own. Additionally, Dr. Feener receives an annual salary of $506,000.00 as Insider at KalVista Pharmaceuticals. Learn More about Edward P. Feener's net worth.
How old is Edward P. Feener?: Dr. Feener is currently 64 years old. There are 6 older executives and no younger executives at KalVista Pharmaceuticals. Learn More on Edward P. Feener's age.
What is Edward P. Feener's salary?: As the Insider of KalVista Pharmaceuticals, Inc., Dr. Feener earns $506,000.00 per year. There are 2 executives that earn more than Dr. Feener. The highest earning executive at KalVista Pharmaceuticals is Mr. Benjamin L. Palleiko, CEO & Director, who commands a salary of $707,100.00 per year. Learn More on Edward P. Feener's salary.
How do I contact Edward P. Feener?: The corporate mailing address for Dr. Feener and other KalVista Pharmaceuticals executives is 55 Cambridge Parkway Suite 901E, CAMBRIDGE MA, 02142. KalVista Pharmaceuticals can also be reached via phone at 857-999-0075 and via email at [email protected]. Learn More on Edward P. Feener's contact information.
Has Edward P. Feener been buying or selling shares of KalVista Pharmaceuticals?: Edward P. Feener has not been actively trading shares of KalVista Pharmaceuticals during the last ninety days. Most recently, Edward P. Feener sold 28,288 shares of the business's stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $14.07, for a transaction totalling $398,012.16. Following the completion of the sale, the insider now directly owns 62,157 shares of the company's stock, valued at $874,548.99. Learn More on Edward P. Feener's trading history.
Who are KalVista Pharmaceuticals' active insiders?: KalVista Pharmaceuticals' insider roster includes Thomas Crockett (CEO), Edward Feener (Insider), Andreas Maetzel (SVP), Michael Smith (VP), and Christopher Yea (Insider). Learn More on KalVista Pharmaceuticals' active insiders.
Are insiders buying or selling shares of KalVista Pharmaceuticals?: During the last year, KalVista Pharmaceuticals insiders bought shares 13 times. They purchased a total of 448,522 shares worth more than $5,806,280.30. During the last year, insiders at the specialty pharmaceutical company sold shares 13 times. They sold a total of 212,109 shares worth more than $2,650,351.15. The most recent insider tranaction occured on February, 20th when insider Edward P Feener sold 28,288 shares worth more than $398,012.16. Insiders at KalVista Pharmaceuticals own 12.3% of the company. Learn More about insider trades at KalVista Pharmaceuticals.
Information on this page was last updated on 2/20/2024.

Edward P. Feener Insider Trading History at KalVista Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/20/2024	Sell	28,288	$14.07	$398,012.16	62,157
1/11/2024	Sell	22,679	$13.03	$295,507.37	39,828
1/8/2024	Sell	17,221	$13.01	$224,045.21	62,607
11/1/2021	Sell	6,000	$18.07	$108,420.00
7/23/2019	Sell	3,300	$18.62	$61,446.00	98,634
4/17/2019	Sell	4,000	$24.92	$99,680.00	100,950
1/16/2019	Sell	4,000	$19.55	$78,200.00	106,334

Edward P. Feener Buying and Selling Activity at KalVista Pharmaceuticals

KalVista Pharmaceuticals Company Overview

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with unmet needs in the United States. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $10.35

$10.32

$11.18

50 Day Range

MA: $12.53

$11.04

$14.86

2 Week Range

Now: $10.35

$7.21

$16.88

Volume

482,316 shs

Average Volume

492,089 shs

Market Capitalization

$436.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

Edward Feener Biography and Net Worth

What is Edward P. Feener's net worth?

How old is Edward P. Feener?

What is Edward P. Feener's salary?

How do I contact Edward P. Feener?

Has Edward P. Feener been buying or selling shares of KalVista Pharmaceuticals?

Who are KalVista Pharmaceuticals' active insiders?

Are insiders buying or selling shares of KalVista Pharmaceuticals?